Article 53. Rights and responsibilities of an establishment providing the service of bioequivalence trial of drugs
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Rights and responsibilities of a pharmaceutical business establishment
1. An establishment providing the service of bioequivalence trial of drugs has the following rights:
a/ The rights prescribed at Points a and b, Clause 1, Article 42 of this Law;
b/ To conduct clinical research and biofluid analysis in the bioequivalence trial of drugs.
In case it only conducts the biofluid analysis, the establishment may contract or cooperate with an establishment conducting clinical trial of drugs and satisfying the good practices of clinical trial of drugs to conduct the clinical research in the bioequivalence trial of drugs;
c/ To conduct bioequivalence trial of drugs under regulations;
d/ To import or purchase chemicals, standard substances and sample drugs to serve the bioequivalence trial of drugs;
dd/ To use results of bioequivalence trial of drugs as agreed with agencies, organizations or individuals having the drugs put for bioequivalence trial.
2. An establishment providing the service of bioequivalence trial of drugs has the following responsibilities:
a/ The responsibilities prescribed at Points a, b, c, d, e, g, h, i, m and n, Clause 2, Article 42 of this Law;
b/ To take responsibility for results of bioequivalence trial of drugs with regard to the drug samples put for trial;
c/ To take responsibility for the safety for persons participating in the bioequivalence trial of drugs and pay compensations to these persons in case a risk occurs due to its fault in accordance with law;
d/ To ensure truthfulness and objectiveness of the bioequivalence trial of drugs;
dd/ To be financially and organizationally independent from agencies, organizations or individuals having the drugs put for bioequivalence trial.
Article 53, Law 105/2016/QH13